These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2327116)

  • 21. [Bioavailability of digoxin tablets in cardiac insufficiency patients].
    Kholodov LE; Grigor'eva EA; Glezer MG; Sabel'nikova EA
    Kardiologiia; 1980 Oct; 20(10):68-73. PubMed ID: 7441963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malabsorption of digoxin tablets, gel caps, and elixir in a patient with an end jejunostomy.
    Ehrenpreis ED; Guerriero S; Nogueras JJ; Carroll MA
    Ann Pharmacother; 1994 Nov; 28(11):1239-40. PubMed ID: 7849335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioavailability of digoxin from rapidly dissolving preparations.
    Johnson BF; Lader S
    Br J Clin Pharmacol; 1974 Aug; 1(4):329-33. PubMed ID: 22454888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioavailability of digoxin capsules and tablets: effect of coadministered fluid volume.
    Bustrack JA; Katz JD; Hull JH; Foster JR; Hammond JE; Christenson RH
    J Pharm Sci; 1984 Oct; 73(10):1397-400. PubMed ID: 6502488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Greater bioavailability of digoxin solution in capsules. Studies in the postprandial state.
    Lindenbaum J
    Clin Pharmacol Ther; 1977 Mar; 21(3):278-82. PubMed ID: 576419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A radioimmunoassay for digoxin in human urine.
    Marwaha RK; Johnson BF
    J Clin Chem Clin Biochem; 1984 Jun; 22(6):403-6. PubMed ID: 6481305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lanoxin--changes in the preparations effect. Important announcement to the country's doctors].
    Flatberg P
    Tidsskr Nor Laegeforen; 1972 Sep; 92(27):1779. PubMed ID: 5076553
    [No Abstract]   [Full Text] [Related]  

  • 28. The assessment of the intrasubject variability in digoxin absorption in man from two oral dosage forms.
    Yacobi A; Stoll RG; Chao GC; Schwartz RA; Weidler DJ; Ayers JW; Sakmar E; Hallmark M; Wagner JG
    J Clin Pharmacol; 1981 Jul; 21(7):301-10. PubMed ID: 7263929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of dietary fiber on the bioavailability of digoxin in capsules.
    Johnson BF; Rodin SM; Hoch K; Shekar V
    J Clin Pharmacol; 1987 Jul; 27(7):487-90. PubMed ID: 2821081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absorption of digoxin from a new microencapsulated formulation.
    Bergdahl B; Bogentoft C; Jonsson UE; Magnusson JO
    Eur J Clin Pharmacol; 1980 Jun; 17(6):443-7. PubMed ID: 7398735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of magnesium--aluminum hydroxide and kaolin--pectin on absorption of digoxin from tablets and capsules.
    Allen MD; Greenblatt DJ; Harmatz JS; Smith TW
    J Clin Pharmacol; 1981 Jan; 21(1):26-30. PubMed ID: 7012189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioavailability of digoxin tablets in healthy volunteers.
    Lee CH; Park YJ; Sands CD; Jones DW; Trang JM
    Arch Pharm Res; 1994 Apr; 17(2):80-6. PubMed ID: 10319136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability and related heart function index of digoxin capsules and tablets in cardiac patients.
    Astorri E; Bianchi G; La Canna G; Assanelli D; Visioli O; Marzo A
    J Pharm Sci; 1979 Jan; 68(1):104-6. PubMed ID: 364006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Equivalence of lanoxin tablets.
    Dobbs SM; Rodgers EM; Woodcock BG
    Br J Clin Pharmacol; 1976 Jun; 3(3):514-5. PubMed ID: 989737
    [No Abstract]   [Full Text] [Related]  

  • 35. Bioavailability of digoxin in a new soluble pharmaceutical formulation in capsules.
    Ghirardi P; Catenazzo G; Mantero O; Merotti GC; Marzo A
    J Pharm Sci; 1977 Feb; 66(2):267-9. PubMed ID: 839426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The bioavailability of digoxin from three oral formulations measured by a specific h.p.l.c. assay.
    Cohen AF; Kroon R; Schoemaker HC; Breimer DD; Van Vliet-Verbeek A; Brandenburg HC
    Br J Clin Pharmacol; 1993 Feb; 35(2):136-42. PubMed ID: 8443031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the in vitro and in vivo release of digoxin from four different soft gelatin capsule formulations.
    Wagner JG; Stoll RG; Weidler DJ; Ayres JW; Hallmark MR; Sakmar E; Yacobi A
    J Pharmacokinet Biopharm; 1979 Apr; 7(2):147-58. PubMed ID: 20218011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioavailability of digoxin in capsules.
    Padeletti L; Brat A
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):320-2. PubMed ID: 669878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model.
    Bansinath M; Ghosh SS; Shukla VK; Chopra KS; Mathur VS
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):303-7. PubMed ID: 3724304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent changes in biological availability of digoxin. Effect of an alteration in 'Lanoxin' tablets.
    Shaw TR; Howard MR; Hamer J
    Br Heart J; 1974 Jan; 36(1):85-9. PubMed ID: 4818143
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.